Inhalopédia | Inhalers

Class
- Long-acting muscarinic antagonist (LAMA)
  Long-acting beta-2 agonist (LABA)
Active ingredient
- Tiotropium (as bromide)
- Olodaterol (as hydrochloride)
Device
- Respimat®
Inhalers techniques and maintenance
Age
- 18 +
Typical use
- Asthma (off-label)
  in addition to an ICS, when uncontrolled on high dose ICS + LABA
Asthma management principles
- COPD
  uncontrolled on 1 bronchodilator (LAMA or LABA)
COPD management principles
Marketed strength
- 2.5/2.5 mcg
Number of doses
- 60 doses
Dose indicator
- Yes | Indicator
Usual adult dosage
- 2 inh QD
Usual pediatric dosage
- -
Required inspiratory flow
- < 30 L/min
  Zero internal resistance (R0)
Inspiratory flows
Public coverage
- MN – NIHB | Open/Regular Benefit
  All provinces except MN – NIHB | Restricted Benefit with criteria
Provincial coverage criteria
Advantages
- Suitable for low inspiratory flows
- Impossible to take empty (locking mechanism)
- Can be used with a spacer
Disadvantages
- Cartridge insertion difficult
- Base turn for loading difficult
- Risk of spraying the face if cap opened before rotating the base
- Occasional cough without spacer
- Synchronism required
Side effects

Product monograph

Download

Inspiolto®